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Chronic kidney disease (CKD) is often characterized by a progressive loss in renal function over a 
period of months or years and by the accumulation of uremic retention solutes in the body. Current 
biomarkers, such as serum creatinine or urinary albumin, lack the sensitivity for early detection of 
CKD, which is primordial towards disease management. In the search for new uremic retention 
solutes and/or biomarkers of CKD, a hydrophilic interaction liquid chromatography time-of-flight 
mass spectrometric (HILIC-TOF MS) platform was developed. Urine and plasma samples from CKD 
patients at stage 3 (n=20), at stage 5 not yet receiving dialysis (n=20) and from healthy controls 
(n=20) were monitored in both positive and negative electrospray ionization mode. The validity of 
the metabolomics dataset was ensured by quality control (QC) samples. Data were treated with 
XCMS followed by multivariate statistical analysis. Differentiation was achieved between the 
metabolic profile of the CKD patients and healthy controls. Moreover, 4 metabolites that showed a 
significant increase or decrease throughout the different stages of CKD, i.e. cinnamoylglycine, 
glycoursodeoxycholic acid, 2-hydroxyethane sulfonate, and pregnenolone sulfate, could be identified 
by the use of authentic standards, the latter three of which are newly detected uremic retention 
solutes. 
 
